Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Axelsson

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Physics and Imaging in Radiation Oncology|July 14, 2021
Registration of histopathology to magnetic resonance imaging of prostate cancerKristina Sandgren, Erik Nilsson, Angsana Keeratijarut Lindberg, et al.
Annals of Clinical and Translational Neurology|October 31, 2019
Cardiovascular factors are related to dopamine integrity and cognition in agingNina Karalija, Anders Wåhlin, Jesper Ek, et al.
Cerebral Cortex (New York, N.Y. : 1991)|October 14, 2017
Latent-Profile Analysis Reveals Behavioral and Brain Correlates of Dopamine-Cognition AssociationsMartin Lövdén, Nina Karalija, Micael Andersson, et al.
Acta Oncologica (Stockholm, Sweden)|October 28, 2025
Ultra-hypofractionated radiotherapy with focal boost for high-risk localized prostate cancer (HYPO-RT-PC-boost): in silico evaluation with histological referenceErik Nilsson, Anneli Nilsson, Joakim Jonsson, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 28, 2023
Impact of simulated reduced injected dose on the assessment of amyloid PET scansPeter Young, Fiona Heeman, Jan Axelsson, et al.
EJNMMI Research|November 17, 2025
Local staging of de novo prostate cancer using mpMRI, PSMA-PET and PSMA-PET/mpMRI - a comparative studyJosefine Grefve, Sara N Strandberg, Joakim Jonsson, et al.
Nuclear Medicine Communications|August 24, 2023
Histopathology-validated lesion detection rates of clinically significant prostate cancer with mpMRI, [ 68 Ga]PSMA-11-PET and [ 11 C]Acetate-PETKristina Sandgren, Sara N Strandberg, Joakim H Jonsson, et al.
Physics and Imaging in Radiation Oncology|September 17, 2024
Histopathology-validated gross tumor volume delineations of intraprostatic lesions using PSMA-positron emission tomography/multiparametric magnetic resonance imagingJosefine Grefve, Karin Söderkvist, Adalsteinn Gunnlaugsson, et al.
Acta Oncologica (Stockholm, Sweden)|June 24, 2024
Accuracy of gross tumour volume delineation with [68Ga]-PSMA-PET compared to histopathology for high-risk prostate cancerMaryam Zarei, Elin Wallsten, Josefine Grefve, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 29, 2026
Quantitative assessment of flow between cerebrospinal and interstitial fluid compartments in humansAnders Wåhlin, Sofia Behndig, Johan Eriksson De Ryst, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Physics and Imaging in Radiation Oncology|July 14, 2021
Registration of histopathology to magnetic resonance imaging of prostate cancerKristina Sandgren, Erik Nilsson, Angsana Keeratijarut Lindberg, et al.
Annals of Clinical and Translational Neurology|October 31, 2019
Cardiovascular factors are related to dopamine integrity and cognition in agingNina Karalija, Anders Wåhlin, Jesper Ek, et al.
Cerebral Cortex (New York, N.Y. : 1991)|October 14, 2017
Latent-Profile Analysis Reveals Behavioral and Brain Correlates of Dopamine-Cognition AssociationsMartin Lövdén, Nina Karalija, Micael Andersson, et al.
Acta Oncologica (Stockholm, Sweden)|October 28, 2025
Ultra-hypofractionated radiotherapy with focal boost for high-risk localized prostate cancer (HYPO-RT-PC-boost): in silico evaluation with histological referenceErik Nilsson, Anneli Nilsson, Joakim Jonsson, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 28, 2023
Impact of simulated reduced injected dose on the assessment of amyloid PET scansPeter Young, Fiona Heeman, Jan Axelsson, et al.
EJNMMI Research|November 17, 2025
Local staging of de novo prostate cancer using mpMRI, PSMA-PET and PSMA-PET/mpMRI - a comparative studyJosefine Grefve, Sara N Strandberg, Joakim Jonsson, et al.
Nuclear Medicine Communications|August 24, 2023
Histopathology-validated lesion detection rates of clinically significant prostate cancer with mpMRI, [ 68 Ga]PSMA-11-PET and [ 11 C]Acetate-PETKristina Sandgren, Sara N Strandberg, Joakim H Jonsson, et al.
Physics and Imaging in Radiation Oncology|September 17, 2024
Histopathology-validated gross tumor volume delineations of intraprostatic lesions using PSMA-positron emission tomography/multiparametric magnetic resonance imagingJosefine Grefve, Karin Söderkvist, Adalsteinn Gunnlaugsson, et al.
Acta Oncologica (Stockholm, Sweden)|June 24, 2024
Accuracy of gross tumour volume delineation with [68Ga]-PSMA-PET compared to histopathology for high-risk prostate cancerMaryam Zarei, Elin Wallsten, Josefine Grefve, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 29, 2026
Quantitative assessment of flow between cerebrospinal and interstitial fluid compartments in humansAnders Wåhlin, Sofia Behndig, Johan Eriksson De Ryst, et al.
Pageof 8